Basit öğe kaydını göster

dc.contributor.authorWALPORT, M
dc.contributor.authorOcal, L
dc.contributor.authorlanchbury, js
dc.contributor.authorISENBERG, D
dc.contributor.authorBRIGGS, D
dc.contributor.authorrussell, kim
dc.contributor.authorbeynon, h
dc.contributor.authorCruickshank, K
dc.date.accessioned2021-03-06T12:11:38Z
dc.date.available2021-03-06T12:11:38Z
dc.date.issued1996
dc.identifier.citationOcal L., russell k., beynon h., Cruickshank K., lanchbury j., WALPORT M., ISENBERG D., BRIGGS D., "Genetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groups", BRITISH JOURNAL OF RHEUMATOLOGY, cilt.35, ss.529-533, 1996
dc.identifier.issn0263-7103
dc.identifier.othervv_1032021
dc.identifier.otherav_f2bb64b8-655f-4cd9-8877-3f20ac517a52
dc.identifier.urihttp://hdl.handle.net/20.500.12627/159184
dc.description.abstractThe aim of this study was to determine whether the TAP2 (Transporter associated with Antigen Processing 2) locus is involved in susceptibility to systemic lupus erythematosus (SLE). We adopted the interethnic approach to overcome problems in the analysis resulting from linkage disequilibrium. The TAP2 gene polymorphisms of the codons corresponding to amino acid positions 379, 565 and 665 were investigated by amplification refractory mutation system polymerase chain reaction (ARMS-PCR) in 186 patients (151 white Europeans, 35 Afrocaribbeans) and 183 controls (79 white Europeans, 104 Afrocaribbeans). In the European SLE patients, the frequency of the TAP2 type V-A-TA was marginally lower compared with the control group (31% vs 42%), with negative linkage disequilibrium between this TAP2 type and DR3 probably accounting for the difference. For the European SLE patients, we confirmed a significant association of DR3 with disease status [odds ratio = 4.16, 95% confidence interval (CI), 2.08-8.39] and in the patients with DR3 there was a significantly high frequency of the TAP2 type V-A-T-. In the Afrocaribbean SLE patients, any associations of disease status with TAP2 phenotype were the inverse of those in the European patients. Thus, in these patients the frequency of V-A-TA was higher than in controls (46% vs 26%, OR = 2.4, 95% CI 1.01-5.74), while the frequency of V-A-T- was lower (26% vs 40%, not significant). Despite possible sampling error, the lack of a difference in TAP2 status between cases and controls within ethnic groups and, if anything, an inverse association across ethnic groups, makes it unlikely that the TAP2 polymorphism studied here is of primary relevance to SLE susceptibility.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleGenetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groups
dc.typeMakale
dc.relation.journalBRITISH JOURNAL OF RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume35
dc.identifier.issue6
dc.identifier.startpage529
dc.identifier.endpage533
dc.contributor.firstauthorID7826


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster